Klin Onkol 2009; 22(2): 73-76.
Keywords: colorectal cancer - chemotherapy - targeted therapy - bevacizumab - irinotecan - capecitabine
Authors: Kocáková Ilona, Kocák Ivo, Svoboda Marek, Němeček Radim, Řehák Zdeněk, Standara Michal2009-04-15:Bevacizumab in combination with capecitabine and irinotecan (XELIR1) in treatment of metastatic colorectal cancer
Keywords: colorectal cancer - chemotherapy - targeted therapy - bevacizumab - irinotecan - capecitabine
Authors: Kocáková Ilona, Kocák Ivo, Svoboda Marek, Němeček Radim, Řehák Zdeněk, Standara Michal2009-04-15:Bevacizumab in combination with capecitabine and irinotecan (XELIR1) in treatment of metastatic colorectal cancer
Klin Onkol 2009; 22(2): 77-79.
Authors: Kepák Tomáš, Radvanská Jitka, Bajčiová Viera, Blatný Marek, Hrstková Hana, Kuře Josef , Mihál Vladimír, Starý Jan, Šmelhaus Vratislav, Štěrba Jaroslav, Koutecký Josef2009-04-15:Long term survivors of childhood cancer: Cure and care. The ERICE statement
Authors: Kepák Tomáš, Radvanská Jitka, Bajčiová Viera, Blatný Marek, Hrstková Hana, Kuře Josef , Mihál Vladimír, Starý Jan, Šmelhaus Vratislav, Štěrba Jaroslav, Koutecký Josef2009-04-15:Long term survivors of childhood cancer: Cure and care. The ERICE statement
Klin Onkol 2009; 22(1): 3-10.
Keywords: trastuzumab, breast cancer, proto-oncogene protein HER-2, treatment effi cacy, drug toxicity
Authors: Grell Peter, Svoboda Marek, Fabián Pavel, Petráková Katarína, Vyzula Rostislav2009-02-15:Clinical aspects of trastuzumab treatment in breast cancer
Keywords: trastuzumab, breast cancer, proto-oncogene protein HER-2, treatment effi cacy, drug toxicity
Authors: Grell Peter, Svoboda Marek, Fabián Pavel, Petráková Katarína, Vyzula Rostislav2009-02-15:Clinical aspects of trastuzumab treatment in breast cancer
Klin Onkol 2009; 22(1): 11-16.
Keywords: tumor stem cells, plasticity, diversity, microenviroment, carcinogenesis
Authors: Ansorgová Veronika, Pleskačová (Mačingová) Zuzana, Priester Peter, Mokrý Jaroslav, Filip Stanislav2009-02-15:Tumor stem cells and ´niche´ – a limiting factors af the carcinogenesis
Keywords: tumor stem cells, plasticity, diversity, microenviroment, carcinogenesis
Authors: Ansorgová Veronika, Pleskačová (Mačingová) Zuzana, Priester Peter, Mokrý Jaroslav, Filip Stanislav2009-02-15:Tumor stem cells and ´niche´ – a limiting factors af the carcinogenesis
Klin Onkol 2009; 22(1): 17-21.
Keywords: cardiotoxicity, left ventricular ejection fraction (LVEF), neoadjuvant chemoterapy adjuvant chemotherapy, radiotherapy.
Authors: Bustová Ivana2009-02-15:Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III
Keywords: cardiotoxicity, left ventricular ejection fraction (LVEF), neoadjuvant chemoterapy adjuvant chemotherapy, radiotherapy.
Authors: Bustová Ivana2009-02-15:Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III
Klin Onkol 2009; 22(1): 22-26.
Keywords: Testicular cancer, chemotherapy, radiotherapy, disease management, relapse, risk factors
Authors: Lakomý Radek, Poprach Alexandr, Němeček Radim, Vyskočil Jiří, Ondrová Barbora, Kocák Ivo, Kocáková Ilona, Řehák Zdeněk2009-02-15:Adjuvant treatment for stage I of testicular germ cell tumours
Keywords: Testicular cancer, chemotherapy, radiotherapy, disease management, relapse, risk factors
Authors: Lakomý Radek, Poprach Alexandr, Němeček Radim, Vyskočil Jiří, Ondrová Barbora, Kocák Ivo, Kocáková Ilona, Řehák Zdeněk2009-02-15:Adjuvant treatment for stage I of testicular germ cell tumours
Klin Onkol 2009; 22(1): 27-33.
Keywords: cetuximab, irinotecan, colorectal cancer.
Authors: Němeček Radim, Kocáková Ilona, Kocák Ivo, Svoboda Marek, Lakomý Radek, Poprach Alexandr, Vyskočil Jiří, Vyzula Rostislav2009-02-15:Cetuximab and Irinitecan for the treatment of metastatic colorectal cancer – pilot results from Masaryk Memorial Cancer Institute
Keywords: cetuximab, irinotecan, colorectal cancer.
Authors: Němeček Radim, Kocáková Ilona, Kocák Ivo, Svoboda Marek, Lakomý Radek, Poprach Alexandr, Vyskočil Jiří, Vyzula Rostislav2009-02-15:Cetuximab and Irinitecan for the treatment of metastatic colorectal cancer – pilot results from Masaryk Memorial Cancer Institute
Klin Onkol 2009; 22(1): 34-37.
Keywords: anthracyclines, cardiotoxicity, cardiomyopathy, heart transplantation
Authors: Urbanová Dagmar, Bubanská Eva, Hrebík M., Mladosievičová Beáta2009-02-15:Severe heart failure in consequence of late anthracycline-induced cardiotoxicity – case report
Keywords: anthracyclines, cardiotoxicity, cardiomyopathy, heart transplantation
Authors: Urbanová Dagmar, Bubanská Eva, Hrebík M., Mladosievičová Beáta2009-02-15:Severe heart failure in consequence of late anthracycline-induced cardiotoxicity – case report
Klin Onkol 2009; 22(1): 38-39.
2009-02-15:Report
2009-02-15:Report
Klin Onkol 2009; 22(1): 40.
2009-02-15:Oncological associations
2009-02-15:Oncological associations
Klin Onkol 2008; 21(6): 317-329.
Keywords: non-small-cell lung cancer, chemotherapy, radiotherapy, targeted therapy
Authors: Skřičková Jana, Čoupek Petr, Jakubíková Lenka, Tomíšková Marcela, Kaplanová Jana, Princ Denis, Kadlec Bohdan, Špelda Stanislav2008-12-15:Treatment of non small cell lung cancer.
Keywords: non-small-cell lung cancer, chemotherapy, radiotherapy, targeted therapy
Authors: Skřičková Jana, Čoupek Petr, Jakubíková Lenka, Tomíšková Marcela, Kaplanová Jana, Princ Denis, Kadlec Bohdan, Špelda Stanislav2008-12-15:Treatment of non small cell lung cancer.
Klin Onkol 2008; 21(6): 330-337.
Keywords: neoadjuvant therapy, rectal adenocarcinomas, prognosis, biomarker, fluoropyrimidines, radiotherapy.
Authors: Garajová Ingrid, Svoboda Marek, Slabý Ondřej, Kocáková Ilona, Fabián Pavel, Kocák Ivo, Vyzula Rostislav2008-12-15:Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorythm
Keywords: neoadjuvant therapy, rectal adenocarcinomas, prognosis, biomarker, fluoropyrimidines, radiotherapy.
Authors: Garajová Ingrid, Svoboda Marek, Slabý Ondřej, Kocáková Ilona, Fabián Pavel, Kocák Ivo, Vyzula Rostislav2008-12-15:Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorythm
Klin Onkol 2008; 21(6): 338-347.
Keywords: epidermal growth factor receptor, radiotherapy
Authors: Sirák Igor, Hátlová Jana, Petera Jiří, Vošmik Milan, Ryška Aleš, Vošmiková Hana2008-12-15:Epidermal growth factor receptor and radiotherapy.
Keywords: epidermal growth factor receptor, radiotherapy
Authors: Sirák Igor, Hátlová Jana, Petera Jiří, Vošmik Milan, Ryška Aleš, Vošmiková Hana2008-12-15:Epidermal growth factor receptor and radiotherapy.
Klin Onkol 2008; 21(6): 348-358.
Keywords: metastatic breast cancer, trastuzumab, HER-2 gene, serum HER-2 protein, time to progression, overall survival, prognosis
Authors: Svoboda Marek, Grell Peter, Šimíčková Marta, Fabián Pavel, Petráková Katarína, Paacova Marketa, Macková Dagmar, Trojanec Radek, Hajdúch Marián, Pavlík Tomáš, Nenutil Rudolf, Vyzula Rostislav2008-12-15:A retrospective analysis of trastuzumab-based therapy in metastatic breast cancer patients at Masaryk Memorial Cancer Institute.
Keywords: metastatic breast cancer, trastuzumab, HER-2 gene, serum HER-2 protein, time to progression, overall survival, prognosis
Authors: Svoboda Marek, Grell Peter, Šimíčková Marta, Fabián Pavel, Petráková Katarína, Paacova Marketa, Macková Dagmar, Trojanec Radek, Hajdúch Marián, Pavlík Tomáš, Nenutil Rudolf, Vyzula Rostislav2008-12-15:A retrospective analysis of trastuzumab-based therapy in metastatic breast cancer patients at Masaryk Memorial Cancer Institute.
Klin Onkol 2008; 21(6): 359.
2008-12-15:Information
2008-12-15:Information